Last reviewed · How we verify

NCT07319104: FECCO-BioBank

Liquid Biopsy in Early Colorectal Lesions

Not yet recruiting Last updated 22 January 2026
What this trial tests

trial testing Venous blood sampling in Colorectal Neoplasms in 1,000 participants. Not yet recruiting.

Timeline
1 March 2026
Primary endpoint
1 December 2028
1 September 2031

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 March 2026
Primary completion1 December 2028
Estimated completion1 September 2031
Sites12 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Colorectal Neoplasms or Precancerous Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Early colorectal cancer screening increasingly detects small superficial colonic lesions, but current diagnostic tools still struggle to distinguish benign from malignant lesions and to assess lymph node risk. As histology after resection has limited accuracy, many patients undergo unnecessary surgery. Liquid biopsy, analyzing circulating biomarkers such as tumor DNA, extracellular vesicles, and nucleosomes, offers a non-invasive way to better classify these lesions. Emerging evidence suggests it may outperform current criteria for predicting lymph node involvement in T1 colorectal cancer. This study will establish a biobank of 1,000 patients to identify blood-based signatures that predict tumor stage and lymph node status. The hypothesis of the study is that circulating biomarkers can accurately differentiate benign from malignant lesions and identify patients with or without lymph node metastasis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Venous blood sampling

Trials testing the same drug.

Other recruiting trials for Colorectal Neoplasms

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07319104.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing